Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
about
Antiviral therapy for symptomatic congenital cytomegalovirus infection in neonates and infants up to 3 months of ageHuman cytomegalovirus: detection of congenital and perinatal infection in ArgentinaUniversal newborn screening for congenital CMV infection: what is the evidence of potential benefit?Cytomegalovirus antivirals and development of improved animal modelsAntiviral drug resistance of human cytomegalovirus.Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant.Perinatal cytomegalovirus hepatitis in Saudi infants: a case series.Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerPrenatal diagnosis of congenital cytomegalovirus infection.Congenital cytomegalovirus infection - An update.Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theUrine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infectionCytomegalovirus infection in pregnancy: review of the literatureValganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts.Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy.Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection.Congenital cytomegalovirus infection. Is there a breakthrough?Impaired surfactant production by alveolar epithelial cells in a SCID-hu lung mouse model of congenital human cytomegalovirus infection.Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study.Advances in the antiviral therapy of herpes virus infection in children.Treatment of congenital cytomegalovirus: where are we now?Diagnosis of congenital cytomegalovirus infection in high risk neonatesWhy CMV is a candidate for elimination and then eradication.Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategiesImmune-based therapies for cytomegalovirus infection.Medical and surgical interventions for hearing loss associated with congenital cytomegalovirus: a systematic review.Question 2: which infants with congenital cytomegalovirus infection benefit from antiviral therapy?Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.The pathogenesis of human cytomegalovirus.Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects.Pharmacokinetic considerations in the use of antivirals in neonates.Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.Treatment of perinatal viral infections to improve neurologic outcomes.Severe neonatal cytomegalovirus infection: about a case.Preventing Congenital Cytomegalovirus Infection.Secondary haemophagocytic lymphohistiocytosis triggered by postnatally acquired cytomegalovirus infection in a late preterm infant.
P2860
Q24248089-2D3C976F-49AC-4A48-B349-A1F30E19A6CEQ24801969-F08A5E0E-8AFC-408D-B059-96190DAC799DQ26824199-06DDFD11-CDCD-4ADE-80AE-3D7AF187FFD3Q27000998-17848A01-7C7F-4419-A880-2D227CAA94F7Q30430427-00900FC6-397E-4378-B802-A353AE2C17DBQ33378098-F125B38D-A2E6-44B1-8BED-57A06FF0878BQ33401411-3A5F7D51-2AC7-47AA-8CD6-B28ADB60C896Q33416429-52F3FE32-1826-443F-B7A5-3BE33BAA14D8Q33650105-7DA6619F-1062-4442-B8CC-611B127A3ECCQ33685279-405E59CE-CA11-4FCD-BEF6-7F10E3719214Q33686813-2F24DCE9-0057-43C2-AB33-153B2193AFFBQ34102747-20EA0E19-418B-4106-BA30-68D3C8F87514Q34212799-9DB0C1FA-387E-4687-BC58-54DF78F602B9Q35293960-D9060721-8D42-4EBB-9EE5-D1D18EECD545Q35755969-7C40C2DF-7CCE-49A6-87D3-3ACC3D9810B8Q35917319-4D9C5A10-E41D-4F65-95D1-398F80FFE707Q35917421-005BBA3B-8D7E-430B-8F9A-FCC613F9C905Q35964751-649699EF-E86E-4CDF-8951-9920FEAA3AD1Q36059266-B52DE8DD-D477-4FF9-AD96-AA3C238CED3AQ36397429-3A4FA1AE-4492-459C-8D2F-86E13FD00732Q36403590-C088392D-DD15-49A0-BFDA-BA7DDDA2D4F9Q36688958-13498321-FE4B-43EC-A8A1-D643B32AE629Q36839732-B299AC75-EE7A-4D68-A5AD-59A21431F533Q37078884-0AC95488-2D45-4ACF-9C32-9741C1185B9CQ37141395-739AB85B-4D2F-4F6F-86D1-100FFFCACD8AQ37153983-682D4AC9-69C8-4D77-815F-CDBABB6271A5Q37773240-98D83B37-2472-4DB2-9899-16A8C76D08F0Q37865225-99A31854-79D0-4C1D-9C7F-0BD75D08047AQ38202451-7358166D-0339-403B-BA73-DD161A2ACE2DQ38215682-50FFCCFD-FFC6-436C-A8AB-BF781F3D29DCQ38247785-7A6E36F5-4617-4F09-B0D5-9EF602EAC3A5Q38260298-E524FF7D-6748-4AC7-9060-3A44C24487EDQ38271850-466420BF-E896-4E56-A270-CFCB9DA1DE86Q38541974-37FCD972-A56C-4C7B-BDDF-ED800F6F990BQ38624965-EF9888FE-5285-4AB9-9BC1-A8B40D6182E9Q38935160-285A3A60-1254-4623-8737-A389159FF126Q38965659-F0298AFC-09DA-4348-AA14-B09710441755Q40047616-B5FF24AD-CBFB-4B83-B416-5B17A9DE0DA8Q40086042-82321F4A-FC08-436F-A8FD-E3128D507371Q40369691-FC6A13BD-705C-4111-8C0C-E729650D857B
P2860
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Ganciclovir treatment of sympt ...... orative Antiviral Study Group.
@ast
Ganciclovir treatment of sympt ...... orative Antiviral Study Group.
@en
type
label
Ganciclovir treatment of sympt ...... orative Antiviral Study Group.
@ast
Ganciclovir treatment of sympt ...... orative Antiviral Study Group.
@en
prefLabel
Ganciclovir treatment of sympt ...... orative Antiviral Study Group.
@ast
Ganciclovir treatment of sympt ...... orative Antiviral Study Group.
@en
P2093
P921
P356
P1476
Ganciclovir treatment of sympt ...... orative Antiviral Study Group.
@en
P2093
Alford C Jr
Demmler GJ
FitzGerald JM
Sherrill L
P304
P356
10.1086/516445
P407
P577
1997-05-01T00:00:00Z